NewcelX
Last verified 2026-05-07. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.4Mattributed |
|---|---|
| Latest round | seed, $3.4M, 2026-04-01attributed |
| Founded | 2024 |
| Headquarters | Geneva |
| Industry | bio |
| Stage | seed |
| Website | newcelx.com |
Stem cell therapies for Type 1 Diabetes
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-01 | seed | $3.4M | undisclosed |
Detected tech stack
Nginx, Vue.js
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $3.4M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $3.4M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | newcelx.com, read 2026-05-07 |
| Description | self-reported | newcelx.com, read 2026-05-07 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.